Literature DB >> 19760114

The challenge of developmentally appropriate care: predictive genetic testing in young people for familial adenomatous polyposis.

Rony E Duncan1, Lynn Gillam, Julian Savulescu, Robert Williamson, John G Rogers, Martin B Delatycki.   

Abstract

Predictive genetic tests for familial adenomatous polyposis (FAP) are routinely offered to young people during early adolescence. While this is not controversial, due to the medical benefit conferred by the test, it is nonetheless challenging as a consequence of the stage of life of the young people, and the simultaneous involvement of multiple family members. Despite these challenges, it is possible to ensure that the test is offered in such a way that it actively acknowledges and facilitates young people's developing autonomy and psychosocial well-being. In this paper we present findings from ten in-depth interviews with young people who have undergone predictive genetic testing for FAP (four male, six female; five gene-positive, five gene-negative; aged 10-17 years at the time of their predictive test; aged 12-25 years at the time of their research interview). We present five themes that emerged from the interviews which highlight key ethical challenges associated with such testing. These are: (1) the significance of the test; (2) young people's lack of involvement in the decision to be tested; (3) young people's limited understanding; (4) provision of the blood test at the first visit; and (5) group testing of family members. We draw on these themes to make eight recommendations for future practice. Together, these recommendations highlight the importance of providing developmentally appropriate care to young people undergoing predictive genetic testing for FAP.

Entities:  

Mesh:

Year:  2009        PMID: 19760114     DOI: 10.1007/s10689-009-9294-0

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  29 in total

Review 1.  Testing children for cancer genes: the rule of earliest onset.

Authors:  E D Kodish
Journal:  J Pediatr       Date:  1999-09       Impact factor: 4.406

2.  Balancing autonomy and responsibility: the ethics of generating and disclosing genetic information.

Authors:  N Hallowell; C Foster; R Eeles; A Ardern-Jones; V Murday; M Watson
Journal:  J Med Ethics       Date:  2003-04       Impact factor: 2.903

3.  Predictive testing of eighteen year olds: counseling challenges.

Authors:  Clara L Gaff; Elly Lynch; Lesley Spencer
Journal:  J Genet Couns       Date:  2006-08       Impact factor: 2.537

4.  Predictive genetic testing in young people for adult-onset conditions: where is the empirical evidence?

Authors:  R E Duncan; M B Delatycki
Journal:  Clin Genet       Date:  2006-01       Impact factor: 4.438

5.  Genetic counseling for pregnant adolescents.

Authors:  T Peters-Brown; L Fry-Mehltretter
Journal:  J Genet Couns       Date:  1996-12       Impact factor: 2.537

6.  The genetic testing of children. Working Party of the Clinical Genetics Society (UK)

Authors:  A Clarke
Journal:  J Med Genet       Date:  1994-10       Impact factor: 6.318

Review 7.  Familial adenomatous polyposis: The practical applications of clinical and molecular screening.

Authors:  Paul Rozen; Finlay Macrae
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

8.  Attitudes toward prenatal genetic testing in patients with familial adenomatous polyposis.

Authors:  Fay Kastrinos; Elena M Stoffel; Judith Balmaña; Sapna Syngal
Journal:  Am J Gastroenterol       Date:  2007-03-13       Impact factor: 10.864

9.  Impact of familial adenomatous polyposis on young adults: quality of life outcomes.

Authors:  L Andrews; S Mireskandari; J Jessen; B Thewes; M Solomon; F Macrae; B Meiser
Journal:  Dis Colon Rectum       Date:  2007-09       Impact factor: 4.585

10.  Parents' responses to predictive genetic testing in their children: report of a single case study.

Authors:  S Michie; V McDonald; M Bobrow; C McKeown; T Marteau
Journal:  J Med Genet       Date:  1996-04       Impact factor: 6.318

View more
  8 in total

Review 1.  Impact of presymptomatic genetic testing on young adults: a systematic review.

Authors:  Lea Godino; Daniela Turchetti; Leigh Jackson; Catherine Hennessy; Heather Skirton
Journal:  Eur J Hum Genet       Date:  2015-07-15       Impact factor: 4.246

2.  Presymptomatic genetic testing for hereditary cancer in young adults: a survey of young adults and parents.

Authors:  Lea Godino; Daniela Turchetti; Leigh Jackson; Catherine Hennessy; Heather Skirton
Journal:  Eur J Hum Genet       Date:  2018-10-04       Impact factor: 4.246

3.  "There's a whole different way of working with adolescents": interviews with Australian Genetic Counselors about their experiences with adolescent clients.

Authors:  Cheryl Tse; Margaret Sahhar; Jane Wallace; Rony E Duncan
Journal:  J Genet Couns       Date:  2013-05-18       Impact factor: 2.537

4.  Subsequent Adenomas of Ileal Pouch and Anorectal Segment after Prophylactic Surgery for Familial Adenomatous Polyposis.

Authors:  A E M'Koma; A J Herline; S E Adunyah
Journal:  World J Colorectal Surg       Date:  2013

5.  A framework for youth-friendly genetic counseling.

Authors:  Mary-Anne Young; Kate Thompson; Jeremy Lewin; Lucy Holland
Journal:  J Community Genet       Date:  2019-11-05

6.  CLINICAL MANAGEMENT OF FAMILIES WITH HEREDITARY COLORECTAL CANCER SYNDROMES.

Authors:  Monica Dandapani; Elena M Stoffel
Journal:  Semin Colon Rectal Surg       Date:  2011-06-01

7.  Experiences of predictive testing in young people at risk of Huntington's disease, familial cardiomyopathy or hereditary breast and ovarian cancer.

Authors:  Rhona MacLeod; Anna Beach; Sasha Henriques; Jasmin Knopp; Katie Nelson; Lauren Kerzin-Storrar
Journal:  Eur J Hum Genet       Date:  2013-07-17       Impact factor: 4.246

8.  How harmful is genetic testing for familial adenomatous polyposis (FAP) in young children; the parents' experience.

Authors:  Anna A Kattentidt-Mouravieva; M den Heijer; I van Kessel; A Wagner
Journal:  Fam Cancer       Date:  2014-09       Impact factor: 2.375

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.